Literature DB >> 33215320

Reporter gene imaging "visualized" the integration of two growing technologies: CRISPR/Cas9-based genome editing and induced pluripotent stem cell therapy.

Arturo Chiti1,2.   

Abstract

Year:  2021        PMID： 33215320     DOI： 10.1007/s00259-020-05117-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  15 in total

Review 1.  Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.

Authors:  Angelos Oikonomopoulos; Tomoya Kitani; Joseph C Wu
Journal:  Mol Ther       Date:  2018-03-06       Impact factor: 11.454

Review 2.  Applications of genetically engineered human pluripotent stem cell reporters in cardiac stem cell biology.

Authors:  Joe Z Zhang; Hongchao Guo; Joseph C Wu
Journal:  Curr Opin Biotechnol       Date:  2018-03-24       Impact factor: 9.740

Review 3.  Imaging: guiding the clinical translation of cardiac stem cell therapy.

Authors:  Patricia K Nguyen; Feng Lan; Yongming Wang; Joseph C Wu
Journal:  Circ Res       Date:  2011-09-30       Impact factor: 17.367

Review 4.  Evolution and classification of the CRISPR-Cas systems.

Authors:  Kira S Makarova; Daniel H Haft; Rodolphe Barrangou; Stan J J Brouns; Emmanuelle Charpentier; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; Yuri I Wolf; Alexander F Yakunin; John van der Oost; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2011-05-09       Impact factor: 60.633

5.  Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.

Authors:  Steven J Kattman; Alec D Witty; Mark Gagliardi; Nicole C Dubois; Maryam Niapour; Akitsu Hotta; James Ellis; Gordon Keller
Journal:  Cell Stem Cell       Date:  2011-02-04       Impact factor: 24.633

6.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

Review 8.  Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges.

Authors:  Pratik A Lalit; Derek J Hei; Amish N Raval; Timothy J Kamp
Journal:  Circ Res       Date:  2014-04-11       Impact factor: 17.367

9.  Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging.

Authors:  Junwei Liu; Kazim H Narsinh; Feng Lan; Li Wang; Patricia K Nguyen; Shijun Hu; Andrew Lee; Leng Han; Yongquan Gong; Mei Huang; Divya Nag; Jarrett Rosenberg; Alexandra Chouldechova; Robert C Robbins; Joseph C Wu
Journal:  Circ Cardiovasc Imaging       Date:  2012-05-07       Impact factor: 7.792

10.  Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy.

Authors:  Filippo Rossignoli; Giulia Grisendi; Carlotta Spano; Giulia Golinelli; Alessandra Recchia; Giulia Rovesti; Giulia Orsi; Elena Veronesi; Edwin M Horwitz; Massimo Dominici
Journal:  Cancer Gene Ther       Date:  2018-06-29       Impact factor: 5.987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.